title: LMO2 and gene therapy for severe combined immunodeficiency.
authors.forename: Alain
authors.initials: A
authors.lastname: Fischer
authors.forename: Salima Hacein-Bey
authors.initials: SH
authors.lastname: Abina
authors.forename: Adrian
authors.initials: A
authors.lastname: Thrasher
authors.forename: Christof
authors.initials: C
authors.lastname: von Kalle
authors.forename: Marina
authors.initials: M
authors.lastname: Cavazzana-Calvo
mesh_terms: D000367:Age Factors; D005786:Gene Expression Regulation; D040181:Genetic Diseases, X-Linked / Q000235:genetics / Q000628:therapy; D015316:Genetic Therapy; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D009857:Oncogenes; D015375:Receptors, Interleukin-2 / Q000235:genetics / Q000378:metabolism; D016511:Severe Combined Immunodeficiency / Q000235:genetics* / Q000628:therapy; D013601:T-Lymphocytes / Q000502:physiology*; D014775:Virus Activation
chemical_list: D007376:Interleukin-2; D015375:Receptors, Interleukin-2